442 related articles for article (PubMed ID: 25345100)
21. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
[TBL] [Abstract][Full Text] [Related]
22. Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease.
Bäumner S; Weber LT
Front Pediatr; 2018; 6():58. PubMed ID: 29594088
[TBL] [Abstract][Full Text] [Related]
23. Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.
Machuca-Gayet I; Quinaux T; Bertholet-Thomas A; Gaillard S; Claramunt-Taberner D; Acquaviva-Bourdain C; Bacchetta J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354056
[TBL] [Abstract][Full Text] [Related]
24. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
25. Cystinosis.
Hohenfellner K; Zerell K; Haffner D
Klin Monbl Augenheilkd; 2023 Mar; 240(3):251-259. PubMed ID: 36977426
[TBL] [Abstract][Full Text] [Related]
26. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
[TBL] [Abstract][Full Text] [Related]
27. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
28. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
29. Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.
Janssens V; Gaide Chevronnay HP; Marie S; Vincent MF; Van Der Smissen P; Nevo N; Vainio S; Nielsen R; Christensen EI; Jouret F; Antignac C; Pierreux CE; Courtoy PJ
J Am Soc Nephrol; 2019 Nov; 30(11):2177-2190. PubMed ID: 31548351
[TBL] [Abstract][Full Text] [Related]
30. [Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
Oczachowska-Kulik AE; Lund AM; Skovby F; Pedersen EB
Ugeskr Laeger; 2011 Aug; 173(33):1958-62. PubMed ID: 21849135
[TBL] [Abstract][Full Text] [Related]
31. Cystinosis: practical tools for diagnosis and treatment.
Wilmer MJ; Schoeber JP; van den Heuvel LP; Levtchenko EN
Pediatr Nephrol; 2011 Feb; 26(2):205-15. PubMed ID: 20734088
[TBL] [Abstract][Full Text] [Related]
32. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
[TBL] [Abstract][Full Text] [Related]
33. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis.
Raggi C; Luciani A; Nevo N; Antignac C; Terryn S; Devuyst O
Hum Mol Genet; 2014 May; 23(9):2266-78. PubMed ID: 24319100
[TBL] [Abstract][Full Text] [Related]
34. Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.
De Leo E; Elmonem MA; Berlingerio SP; Berquez M; Festa BP; Raso R; Bellomo F; Starborg T; Janssen MJ; Abbaszadeh Z; Cairoli S; Goffredo BM; Masereeuw R; Devuyst O; Lowe M; Levtchenko E; Luciani A; Emma F; Rega LR
J Am Soc Nephrol; 2020 Jul; 31(7):1522-1537. PubMed ID: 32503896
[TBL] [Abstract][Full Text] [Related]
35. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
36. Altered mTOR signalling in nephropathic cystinosis.
Ivanova EA; van den Heuvel LP; Elmonem MA; De Smedt H; Missiaen L; Pastore A; Mekahli D; Bultynck G; Levtchenko EN
J Inherit Metab Dis; 2016 May; 39(3):457-464. PubMed ID: 26909499
[TBL] [Abstract][Full Text] [Related]
37. Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.
Veys KRP; Elmonem MA; Van Dyck M; Janssen MC; Cornelissen EAM; Hohenfellner K; Prencipe G; van den Heuvel LP; Levtchenko E
J Am Soc Nephrol; 2020 May; 31(5):1092-1106. PubMed ID: 32273301
[TBL] [Abstract][Full Text] [Related]
38. Endo-lysosomal dysfunction in human proximal tubular epithelial cells deficient for lysosomal cystine transporter cystinosin.
Ivanova EA; De Leo MG; Van Den Heuvel L; Pastore A; Dijkman H; De Matteis MA; Levtchenko EN
PLoS One; 2015; 10(3):e0120998. PubMed ID: 25811383
[TBL] [Abstract][Full Text] [Related]
39. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696
[TBL] [Abstract][Full Text] [Related]
40. Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.
Jamalpoor A; van Gelder CA; Yousef Yengej FA; Zaal EA; Berlingerio SP; Veys KR; Pou Casellas C; Voskuil K; Essa K; Ammerlaan CM; Rega LR; van der Welle RE; Lilien MR; Rookmaaker MB; Clevers H; Klumperman J; Levtchenko E; Berkers CR; Verhaar MC; Altelaar M; Masereeuw R; Janssen MJ
EMBO Mol Med; 2021 Jul; 13(7):e13067. PubMed ID: 34165243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
